BMO cuts Atlassian stock price target on lower revenue outlook By Investing.com

Atlassian delivered a solid Q3 fiscal 2026 beat, with EPS of $1.75 versus $0.98 expected and revenue of $1.79 billion versus $1.57 billion consensus. BMO Capital cut its price target to $105 from $130 but kept an Outperform rating, citing roughly 13% FY27 revenue growth and strong 84% gross margins. The update is constructive overall but tempered by a lower target and the stock's already elevated valuation backdrop.

Analysis

The key second-order read-through is that the market is still pricing Atlassian as a slower-growth SaaS story, while management is proving it can still generate both operating leverage and meaningful product-cycle optionality. That creates a setup where multiple expansion is possible even if consensus revenue models only drift modestly higher, because the debate is shifting from “can growth persist?” to “how durable is FCF per share once the platform mix improves?” The margin signal matters more than the headline beat: if investors start underwriting higher terminal cash conversion, the stock can re-rate well before top-line acceleration re-accelerates.

The likely winners are adjacent collaboration/software infrastructure vendors that can piggyback on a renewed spending cycle around enterprise dev productivity and workflow consolidation. The underappreciated loser is any short-duration SaaS basket that was leaning on a “mature software” thesis; Atlassian’s print makes it harder to argue that high-quality horizontal software should be valued like low-growth IT. The timing also matters: the next catalyst is the product event, so the market may be underpricing a second leg if collections/new offerings are framed as monetization levers rather than feature updates.

The main risk is that the stock has already moved from deep capitulation to selective optimism, so the near-term path may be less about fundamentals and more about whether the event can justify the current re-rating. If management fails to show fiscal 2027 can re-accelerate beyond low-teens growth, the multiple could compress quickly because the bear case remains centered on durability, not execution. In that sense, the setup is better for tactical trades than long-only complacency: upside needs incremental narrative proof, while downside can resume if the event disappoints.

Contrarian view: consensus may be over-focusing on the lower price target and underestimating how cheap 10x FCF looks for a category leader with strong margins and visible product expansion. The market may also be misreading the current weakness as structural when it may simply reflect a reset in expectations after a long derating cycle. If the company can demonstrate that new offerings increase wallet share rather than just add complexity, the next leg could be driven by estimate revisions rather than multiple expansion alone.

Key Decisions for Investors

• Go long TEAM into the product event over the next 1-3 weeks, targeting a 12-18% upside move if management converts margin strength into FY27 growth confidence; trail a tight stop if post-event guidance lacks acceleration.
• Buy TEAM Jan-2027 calls or call spreads to express a medium-term re-rating thesis with defined downside; attractive if implied vol remains below the stock’s event-driven realized range.
• Pair trade: long TEAM / short a weaker-quality mid-cap SaaS basket over 1-2 months, betting that capital rotates toward durable FCF stories if enterprise software multiples stabilize.
• If TEAM rallies >10% into the event, take partial profits or hedge with short-dated calls; the near-term risk is a classic “buy the rumor, sell the news” compression if new product disclosures are incremental.